meta_pixel
Tapesearch Logo
Log in
It's Been a Minute

GLP-1s & eating disorders: a complicated relationship

It's Been a Minute

NPR

News, News Commentary, Religion & Spirituality, Society & Culture, Spirituality

4.79.2K Ratings

🗓️ 27 May 2026

⏱️ 21 minutes

🧾️ Download transcript

Summary

What happens when GLP-1s interact with eating disorders?

About 1 in 8 US adults are currently taking a GLP-1. They’ve been described by a lot of people as a miracle drug – they treat high blood sugar and diabetes, and have also shown promise as a treatment for addiction and metabolic conditions like PMOS, formerly known as PCOS. And a lot of Americans are taking it for one reason: weight loss. But for people with eating disorders, that weight loss could be dangerous. So even though GLP-1s are a miracle drug for many struggling with certain health conditions – what does it mean that they’re becoming incredibly available to everyone? And how do we reckon with their place in a culture that prioritizes thinness… sometimes to the point of real danger to someone’s health?

Brittany is joined by Dr. Allegra Broft, a psychiatrist and an assistant professor at Columbia University Medical Center who specializes in eating disorders, and Hannah Seo, an independent journalist who wrote about GLP-1s and eating disorders for The Guardian.

For more episodes about weight, body image, and culture, check out:
Peptides & the pursuit of the "perfect" body
The difference between losing weight & being "healthy"
The strange politics of Pilates

Support Public Media. Join NPR Plus.

Follow Brittany on Instagram: @bmluse

For handpicked podcast recommendations every week, subscribe to NPR’s Pod Club newsletter at npr.org/podclub.

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

NPR Privacy Policy

Transcript

Click on a timestamp to play from that location

0:00.0

According to a poll from the Kaiser Family Foundation, about one in eight U.S. adults are currently

0:07.8

taking a GLP1. They've been described by a lot of people as a miracle drug. They're used to treat

0:13.5

high blood sugar and diabetes, but they've also shown promise as a treatment for addiction

0:18.7

and metabolic conditions like PMOS, formerly known as PCOS.

0:22.6

But a lot of Americans are taking it for one reason.

0:26.6

Weight loss.

0:27.6

Which actually doesn't happen for everyone on a GLP1, but for people with eating disorders, that weight loss could be dangerous.

0:34.6

Layla Taylor, one of the cast members of the secret lives

0:37.6

of Mormon wives, made headlines earlier this year when she opened up about getting on a GLP1

0:42.3

to fuel an eating disorder. And a lot of people started chattering online when a recent piece

0:47.8

in the cut went viral about women in eating disorder recovery who cut off a friend going on with

0:53.5

Govi. I've been thinking about these two moments a lot because like eating disorder recovery who cut off a friend going on with Govi.

0:59.5

I've been thinking about these two moments a lot because like eating disorders are fairly common.

1:05.1

According to the National Eating Disorders Association, about one in ten Americans will have an eating disorder in their lifetime. And even for those who don't, I wouldn't say our culture

1:10.0

promotes a very healthy relationship to food and our bodies.

1:13.7

So even though GLP-1s are a miracle drug for many struggling with certain health conditions,

1:18.5

what does it mean that they're becoming incredibly available to everyone?

1:23.1

And how do we reckon with its place in a culture that prioritizes thinness,

1:30.9

sometimes to the point of real danger to someone's health?

1:38.8

To get into it, I'm joined by Allegra Broft, a psychiatrist and an assistant professor at Columbia University Medical Center who specializes in eating disorders.

1:39.8

Welcome, Allegra.

1:40.9

Thank you for having me.

...

Transcript will be available on the free plan in 19 days. Upgrade to see the full transcript now.

Disclaimer: The podcast and artwork embedded on this page are from NPR, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of NPR and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.